FLANAGAN, KENNETH,TAM, STEPHEN JED,LIU, YUE,YEDNOCK, THEODORE,BARBOUR, ROBIN
申请号:
CA2938931
公开号:
CA2938931A1
申请日:
2015.03.12
申请国别(地区):
CA
年份:
2015
代理人:
摘要:
The invention provides antibodies that specifically bind to the LG1-3 modules of the G domain of laminin a4. The antibodies have the capacity to inhibit binding of laminin a4 to MCAM. The antibodies can be used for inhibiting undesired immune responses, treatment of cancer, or treatment of obesity or obesity-related diseases, among other applications.